Breast cancer treatment of older women in integrated health care settings

Journal of Clinical Oncology

Volumn 24, Issue 27, 2006, Pages 4377-4383

  Enger, Shelley M ^b   Soe, Soe Thwin ^b   Buist, Diana S M ^b   Field, Terry ^b   Frost, Floyd ^b   Geiger, Ann M ^b   Lash, Timothy L ^b   Prout, Marianne ^b   Yood, Marianne Ulcickas ^b   Wei, Feifei ^b   Silliman, Rebecca A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AFRICAN AMERICAN; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGE; ASIAN AMERICAN; BREAST TUMOR; CLINICAL TRIAL; HEALTH INSURANCE; INTEGRATED HEALTH CARE SYSTEM; MASTECTOMY; METHODOLOGY; MULTICENTER STUDY; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN AMERICANS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HUMANS; MANAGED CARE PROGRAMS; MASTECTOMY; MEDICAL RECORDS; ODDS RATIO; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TAMOXIFEN; TREATMENT OUTCOME; UNITED STATES;

EID: 33749058934     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.3065     Document Type: Article

References (47)

1. Silliman RA, Guadagnoli E, Weitberg AB, et al: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44:M46-M50, 1989
2. Ballard-Barbash R, Potosky AL, Harlan LC, et al: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716-726, 1996
3. Silliman RA, Troyan SL, Guadagnoli E, et al: The impact of age, marital status, and physician-patient interactions on the care of older women with breast cancer. Cancer 80:1326-1334, 1997
4. Hebert-Croteau N, Brisson J, Latreille J, et al: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:104-113, 1999
5. Mandelblatt JS, Hadley J, Kerner JF, et al: Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physician influences. Cancer 89:561-573, 2000
6. Liberati A, Apolone G, Nicolucci A, et al: The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer. Am J Public Health 81:38-42, 1991
7. Silliman RA, Demissie S, Troyan SL: The care of women with early stage breast cancer: What is the role of surgeon gender? Med Care 37:1057-1067, 1999
8. Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor positive breast cancer. J Clin Oncol 22:3309-3315, 2004
9. Goodwin JS, Hunt WC, Key CR, et al: The effect of marital status on stage, treatment, and survival of cancer. JAMA 258:3125-3130, 1987
10. Ward S, Heidrick S, Wolberg W: Factors women take into account when deciding upon type of surgery for breast cancer. Cancer Nurs 12:344-351, 1989
11. Bradley CJ, Given CW, Roberts C: Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490-496, 2002
12. McWhorter WP, Mayer WJ: Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 77:1515-1517, 1987
13. Washington State Hospital Association: Governing Board Orientation Manual. http://www.wsha.org/GoverningBoardManual/integrateddelivery. html#integrateddeliverysystem
14. Riley GF, Potosky AL, Lubitz JD, et al: Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 84:1598-1604, 1994
15. Riley GF, Potosky AL, Klabunde CN, et al: Stage at diagnosis and treatment patterns among older women with breast cancer: An HMO and fee-for-service comparison. JAMA 281:720-726, 1999
16. Miller R, Luft H: Managed care plan performance since 1980: A literature analysis. JAMA 271:1512-1519, 1994
17. Potosky AL, Breen N, Braubard BI, et al: The association between health care coverage and the use of cancer screening tests. Med Care 36:257-270, 1998
18. Wagner EH, Greene SM, Hart G, et al: Building a research consortium of large health systems: The Cancer Research Network. J Natl Cancer Inst Monogr 35:3-11, 2005
19. Fleming ID, Cooper JS, Henson DE, et al: AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott Williams & Wilkins, 1997
20. Brown ML, Hankey BF, Ballard-Barbash R: Measuring the quality of breast cancer care. Ann Intern Med 133:920, 2000
21. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
22. Buechley RW: A reproducible method of counting persons of Spanish surname. J Am Stat Assoc 56:88-97, 1961
23. Frost F, Tellestrup K, Trinkaus K, et al: Mammography screening and breast cancer tumor size in female members of a managed care organization. Cancer Epidemiol Biomarkers Prev 7:585-589, 1998
24. Glick JH, Gelber RD, Goldhirsch A, et al: Meeting highlights: Adjuvant therapy for primary breast cancer. J Natl Cancer Inst 84:1479-1485, 1992
25. NIH Consensus Conference: Treatment of early stage breast cancer. JAMA 265:391-395, 1991
26. SAS Institute: The Genmod Procedure, Model Statement: Manual, SAS Version 9.1. Cary, NC, The SAS Institute, 2002-2003
27. Giordano SH, Hortobagyi GN, Kau SW, et al: Breast cancer treatment guidelines in older women. J Clin Oncol 23:783-791, 2005
28. Voti L, Richardson LC, Reis I, et al: The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat 95:89-95, 2006
29. National Center for Health Statistics: Life tables of the United States, 1997. http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs/lewk3.htm
30. Bland KI, Scott-Conner CE, Menck H, et al: Axillary dissection in breast-conserving surgery for stage I and II breast cancer: A National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188:586-595, 1999
31. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005
32. Cox CE, Dupont E, Whitehead GF, et al: Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 8:88-91, 2002
33. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004
34. Goel MS, Burns RB, Phillips RS, et al: Trends in breast conserving surgery among Asian Americans and Pacific Islanders, 1992-2000. J Gen Intern Med 20:604-611, 2005
35. Hiotis K, Ye W, Sposto R, et al: Predictors of breast conservation therapy. Cancer 103:892-899, 2005
36. Li IC, Malone KE, Dating JR: Differences in breast cancer stage, treatment and survival by race and ethnicity. Arch Intern Med 163:49-56, 2003
37. Prehn AW, Topol B, Stewart S, et al: Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women. Cancer 95:2268-2275, 2002
38. Legorreta AP, Liu X, Parker RG: Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment. Am J Clin Oncol 23:438-441, 2000
39. Kotwall CA, Covington DL, Rutledge R, et al: Patient, hospital, and surgeon factors associated with breast conservation surgery. Ann Surg 224:419-429, 1996
40. Gilligan MA, Kneusel RT, Hoffmann RG, et al: Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40:181-189, 2002
41. Guadagnoli E, Shapiro C, Gurwitz JH, et al: Age-related patterns of care: Evidence against ageism in the treatment of early-stage breast cancer. J Clin Oncol 15:2338-2344, 1997
42. Du XL, Key CR, Osborne C, et al: Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 138:90-97, 2003
43. Lyman GH, Dale DC, Crawford J: Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices. J Clin Oncol 21:4524-4531, 2003
44. Silliman RA, Guadagnoli E, Rakowski W, et al: Adjuvant tamoxifen prescription in women 65 years and older with early stage breast cancer. J Clin Oncol 20:2680-2688, 2002
45. Du XL, Jones DV, Zhang D: Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women. J Gerontol 60A:1137-1144, 2005
46. Buchholz TA, Theriault TA, Theriault RL, et al: The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network centers. J Clin Oncol 24:361-369, 2006
47. Chagpor AB, Studts JL, Scoggins CR, et al: Factors associated with surgical options for breast carcinoma. Cancer 106:1462-1466, 2006